Germ Cells Tumors - 22 Studies Found
Recruiting |
: Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors : Germ Cell Tumor : 2017-02-28 :
|
Completed |
: Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors : Germ Cell Tumors : 2007-12-11 :
|
Recruiting |
: Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors : Germ Cell Tumors : 2013-06-05 :
|
Recruiting |
: Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor : Testicular Germ Cell Tumor : 2016-02-05 : Other: EORTC QLQ-CIPN20 EORTC QLQ-CIPN20 is a 20-item chemotherapy-induced peripheral neuropathy-specifi |
Recruiting |
: A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor : Testicular Germ Cell Tumor : 2014-04-08 : Other: Phone interview and blood test Subjects will be interviewed about environmental, domestic and occ |
Recruiting |
: A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent : Extra Cranial Non Seminomateous Malignant Germ Cell Tumour : 2014-03-27 :
|
Recruiting |
: A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors : Non-seminomatous Germ-cell Tumors : 2014-04-10 : Drug: Cabazitaxel On Day 1 of each cycle, patients will receive cabazitaxel at a dose of 25 mg/m², |
Completed |
: Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin :
: 1999-11-01 :
|
Recruiting |
: A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors : Relapsed / Recurrent Germ Cell Tumors : 2013-09-20 :
|
Recruiting |
: Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor : Intracranial Non-germinomatous Germ Cell Tumor : 2016-05-24 :
|